Pharmaceutics

This page contains key pharmaceutical news on drug recalls, FDA clearance, safety communications and research. In cardiology, key pharmaceutic agents include antiplatelet therapies, anticoagulants, hypertension drugs, and drugs for heart failure and arrhythmias.   

RSS icon
Patient in hospital bed

Metoprolol demonstrates value as a treatment for obstructive hypertrophic cardiomyopathy

The small study, published in the Journal of the American College of Cardiology, compared patient outcomes associated with metoprolol and a placebo. 

December 20, 2021
Patient doctor with masks. A team of specialists from Cleveland Clinic reviewed nearly 3,000 medications, writing that a common type 2 diabetes medication offered the most potential as an effective treatment for AFib. 

DOACs outperform VKAs among cardiac amyloidosis patients with HF, AFib

Outcomes from patients prescribed apixaban, rivaroxaban or dabigatran were compared with outcomes from patients given warfarin. 

December 2, 2021

Generic statin options can save the US $11.9B per year

The study tracked five generic statins: atorvastatin, rosuvastatin, simvastatin, lovastatin and pravastatin.

November 23, 2021
thumbnail_krishnaswamy_amar_760171_1.jpg

Q&A: Cleveland Clinic cardiologist details the past, present and future of drug-eluting stents

Amar Krishnaswamy, MD, shared his thoughts on this important technology in an exclusive interview. 

November 22, 2021
Doctor patient

AFib patients able to safely transition from warfarin to a DOAC

The new analysis, published in the Journal of the American Heart Association, explored what happens with AFib patients shift their anticoagulant strategy. 

November 19, 2021

Black, Hispanic AFib patients less likely to start anticoagulant therapy, new VA study finds

Researchers wrote that they hope their findings can help guide the creation of policies that reduce disparities in care for AFib patients. 

November 18, 2021
New findings out of the University of Missouri suggests that the long-lasting impact of COVID-19 may not be quite as substantial as some researchers originally believed. The study’s authors evaluated nearly 50 different symptoms to see if they were more common up to one year after a person has been infected with COVID-19. They found, however, that this was true of just seven symptoms: heart palpitations, chest pain, shortness of breath, joint pain, hair loss, fatigue and obesity. #COVID19 #longCOVID

High-dose icosapent ethyl treatment makes minimal impact on non-hospitalized COVID-19 patients

The analysis, presented at AHA Scientific Sessions 2021, included approximately 2,000 symptomatic COVID-19 patients who were not necessarily sick enough to be hospitalized. 

November 16, 2021
Continuous and high-adherent statin users had lower baseline arterial stiffness which also grew more slowly over time, a new JAMA Network Open study finds.

Statin use may increase the risk of severe illness among COVID-19 patients

The new analysis emphasized, however, that COVID-19 mortality did not appear to be affected by prior statin use.  

October 28, 2021
Displaying 193 - 200 of 238

Around the web

Health Imaging
New imaging protocols proposed to curb rise of cardiovascular infections

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.

Radiology Business
What does radiology have to do with climate change?

Kate Hanneman, MD, explains why many vendors and hospitals want to lower radiology's impact on the environment. "Taking steps to reduce the carbon footprint in healthcare isn’t just an opportunity," she said. "It’s also a responsibility."

Design by Adaptive Theme
Trimed Popup
Trimed Popup